A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dettagli Bibliografici
Autore principale:	Islam, Nahidul
Altri autori:	Talukder, Mesbah
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2023
Soggetti:	Psoriasis Biologics FAERS Interleukin inhibitors Alopecia Pharmacovigilance
Accesso online:	http://hdl.handle.net/10361/22025

Documenti analoghi

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
di: Afroza, Halima
Pubblicazione: (2024)

Biologics and Biosimilars as Treatment Options for Psoriasis
di: Moya, Amena Khatun
Pubblicazione: (2023)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
di: Bishakha, Adwiza Chakraborty
Pubblicazione: (2024)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
di: Islam, S.M. Zahidul
Pubblicazione: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
di: Khandker, Tahia Anjum
Pubblicazione: (2024)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
di: Onanna, Kazi
Pubblicazione: (2024)

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
di: Nusrat, Tanzina
Pubblicazione: (2019)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
di: Rahman, Ahadina
Pubblicazione: (2018)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
di: Meem, Manila
Pubblicazione: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
di: Islam, Saidul
Pubblicazione: (2022)

A survey on the knowledge and attitude on pharmacovigilance among the pharmacy students of different universities of Dhaka, Bangladesh
di: Albee, Md. Hamza
Pubblicazione: (2017)

Identification of FAP inhibitors using in silico simulation study
di: Deeba, Maliha Tasnim
Pubblicazione: (2018)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
di: Karim, Azrin
Pubblicazione: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
di: Jahan, Safrin
Pubblicazione: (2023)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
di: Tabassum, Nadira
Pubblicazione: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
di: Akter, Anika
Pubblicazione: (2022)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
di: Shehab, Habibul Mohsin
Pubblicazione: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
di: Haque, Mushfiqul
Pubblicazione: (2019)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
di: Bakar, Osama Bin Abu
Pubblicazione: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
di: Khan, Muidul Hasan
Pubblicazione: (2024)

Biomarkers in the diagnosis and treatment of Covid-19
di: Kabir, Syeda Shuvessa
Pubblicazione: (2023)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
di: Oshin, Sadia Afrin
Pubblicazione: (2021)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
di: Mahin, Md. Tamjidur Rahman
Pubblicazione: (2024)

Female Alopecia
di: TrÃ¼eb
Pubblicazione: (2013)

RIPK pathway, as a potential target, for cancer treatment - a review
di: Jahan, Nusrat
Pubblicazione: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
di: Rattry, Faria Rahman
Pubblicazione: (2024)

Recent advancement of biologics in Asthma
di: Evan, Al- Shahriar
Pubblicazione: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
di: Sorno, Rubina Haque
Pubblicazione: (2024)

Cross-sectional survey to assess the knowledge, attitude and practice regarding adverse drug reactions of students of a private university
di: Islam, Tarikul
Pubblicazione: (2021)

A study on drug product approval by the FDA from 1930 to 2019
di: Jony, Md. Nazmul Islam
Pubblicazione: (2023)

Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
di: Hossain, Ragib
Pubblicazione: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
di: Emon, Kamrul Hasan
Pubblicazione: (2022)

FDA Consumer

FDA Consumer

FDA Consumer

FDA Consumer

Detection of skin diseases using deep learning
di: Shodoy, Masuk Ur Rahman
Pubblicazione: (2024)

Assessment of knowledge and attitude of adverse Ddug reactions among healthcare professionals in Bangladesh
di: Paul, Sanjoy Kumer
Pubblicazione: (2021)

Pharmacoepidemiology and Pharmacovigilance